Frontiers in Mathematical Modeling for Vaccine and Antiviral Drug Development: Advances and Applications
Math Vanquishes Viruses and Banishes Bacteria
Jeff (Jeffrey R.) Sachs（ISoP; MSD）
Establishing Immune Correlates of Protection Against RSV: MBMA Approach to Accelerate Vaccine Development
Yushi Kashihara（Daiichi Sankyo Co. Ltd.）
Role of Pharmacometricians in Anti-Infective Drug Development: Current Practice and Future Perspectives for Advancing MIDD
Satoshi Shoji（Pfizer R&D Japan）
Viral Dynamics and Antiviral Therapy in Immunocompromised Patients
Shingo Iwami（Nagoya University）
Panel Discussion
